首页> 外国专利> Pharmaceutical composition comprising Metformin or its Salt acceptable for pharmaceutical use with glimepiride and metformin or its Salt acceptable for pharmaceutical use and glimepiride for the manufacture of a medicament

Pharmaceutical composition comprising Metformin or its Salt acceptable for pharmaceutical use with glimepiride and metformin or its Salt acceptable for pharmaceutical use and glimepiride for the manufacture of a medicament

机译:药物组合物,其包含可药用的二甲双胍或其盐与格列美脲和可药用的二甲双胍或其盐以及格列美脲用于制造药物

摘要

A Pharmaceutical composition comprising Metformin or its Salt acceptable for pharmaceutical use, such as hydrochloride, succinate or fumarate with glimepiride Mixed according to different formulations excipients used depend on the ratio of the two active substances.The ratio between the two active substances can be either combinations where Metformin or its Salt acceptable for pharmaceutical use is maintained in the range of 100 to 10000 mg and mg glimepiride is maintained in the range of 0.1 to 20 mg.Use of Metformin or its Salt acceptable for pharmaceutical use and glimepiride for the manufacture of a Medicament useful for Blood glucose control in patients with Type 2 diabetes. Clinical studies have shown a synergistic effect compared with monotherapy. Applies in the field of oral hypoglycemic agents.
机译:包含可药用的二甲双胍或其盐的药物组合物,例如盐酸盐,琥珀酸盐或富马酸盐与格列美脲混合使用根据不同制剂的赋形剂取决于两种活性物质的比例两种活性物质之间的比例可以是两种组合药物可接受的二甲双胍或其盐的含量保持在100至10000 mg范围内,格列美脲的mg保持在0.1至20 mg的范围内。可用于控制2型糖尿病患者血糖的药物。临床研究表明与单药治疗相比有协同作用。适用于口服降糖药领域。

著录项

  • 公开/公告号AR050684A1

    专利类型

  • 公开/公告日2006-11-15

    原文格式PDF

  • 申请/专利权人 LABORATORIOS SILANES S.A. DE C.V.;

    申请/专利号AR2005P103077

  • 发明设计人 LARA OCHOA JOSE MANUEL FRANCISCO;

    申请日2005-07-25

  • 分类号A61K31/155;A61K31/64;A61P3/10;

  • 国家 AR

  • 入库时间 2022-08-21 20:59:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号